1 rich Libsyn https://www.libsyn.com 90 600 This is the second episode of our new &quot;Program on JAK Inhibitors for Atopic Dermatitis&quot; series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, &quot;JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis&quot;, featuring expert dermatologist Dr. James Song, MD, discusses the following topics: Short- and long-term efficacy and safety data for JAK inhibitor therapies&amp;nbsp; New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD&amp;nbsp; Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies&amp;nbsp; Emerging clinical developments and what's coming next in JAK inhibitor research&amp;nbsp; DermDocs http://dermdocs.libsyn.com/website <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/31457067/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/172434162